The ABL Advisor Deal Tables
SELECTED TRANSACTION DETAILS
Comerica Bank Provides $7.5MM Credit Facility to Interpace Biosciences
|
Lenders/Participants
|
Comerica Bank [Lender]
|
|
Structure
|
Revolving Credit Facility
|
|
Amount
|
$7.500
Million
|
|
Borrower(s)
|
Interpace Biosciences
|
|
Description
|
The facility matures on September 30, 2023 and allows for advances based on 80% of eligible accounts receivable plus an applicable non-formula amount consisting of $2,000,000 of additional availability at close, stepping down $250,000 per quarter beginning with the quarter ending June 30, 2022. The interest rate is equal to prime plus .50%, prime being the greater of the bank’s stated prime rate or the sum of the daily adjusting LIBOR rate, plus 2.5% per annum. The Bank will have a first priority security interest in substantially all of Interpace’s and its subsidiaries’ assets and will be senior to the existing $7.5 Million bridge loans made by the Company’s private equity investors.
|
|
Industry
|
Biotechnology
|
ABL Advisor
Deal Tables
2024
|
|
|
|